|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/62 | |
| C12N 15/70 | |||
| C12N 1/21 | |||
| C07K 16/00 | |||
| C07K 14/515 | |||
| C07K 14/475 | |||
| C07K 14/52 | |||
| C07K 14/505 |
| (11) | Number of the document | 1797127 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05814444.5 |
| Date of filing the European patent application | 2005-09-23 | |
| (97) | Date of publication of the European application | 2007-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/034273 |
| Date | 2005-09-23 |
| (87) | Number | WO 2006/036834 |
| Date | 2006-04-06 |
| (30) | Number | Date | Country code |
| 612680 P | 2004-09-24 | US |
| (72) |
GEGG, Collin, US
XIONG, Fei, US
SITNEY, Karen, C, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive M/S 28-2-C, Thousand Oaks, CA 91320-1799,
US
|
| (54) | MODIFIED FC MOLECULES |
| MODIFIED FC MOLECULES |